Fireside Chat Replay: Clinical Trials in Rare Disease: Best Practices for Integrating the Patient Voice

On-demand webinar

Multimedia
Published on:
April 13, 2022

Clinical trials in rare diseases are traditionally more challenging than trials in more common diseases. Sponsors and researchers are well aware that issues such as a small pool of potential participants and the complexities of trial participation often make the overall process less efficient and can slow down the delivery of life-changing medicines to the global market.

An often-overlooked component of the clinical trial design and execution process in rare diseases is the importance of the most crucial stakeholder: the patient. During this fireside chat, we discussed some practical suggestions on how to engage patients in the clinical trial process.

Here is what you will learn:

How to improve the design of your clinical trials through the involvement of patient representatives

How to choose outcomes relevant to patients

How to increase patient retention and compliance through early engagement

How to engage successfully with patient-centric stakeholders, such as patient organizations, for the success of a clinical trial

Meet the speakers

Chris Rao – Senior Vice President, Clinical Development, Alira Health

Christopher has 15 years of experience in clinical research, with a focus on clinical trial design and operations. As a strategist, Christopher works identifies client’s key needs early and creates tailored, targeted plans for clinical development and market success. Throughout his career, Christopher has worked closely with small-to-medium biotech and pharmaceutical oncology companies, developing novel technologies.

Trishna Bharadia – Health Advocate and Patient Engagement Consultant, The Spark Global

Trishna BharadiaTrishna Bharadia, BA(hons), MFPM(Hon) is a multi-award winning health advocate and patient engagement consultant working to get the patient voice heard louder, stronger and more effectively throughout the healthcare journey and medicines development lifecycle. From the UK, she works nationally and internationally with multiple stakeholders, including industry, healthcare systems, clinicians and patient organizations. Her work includes consultancy, co-creation of services and information, writing and media outreach. She lives with several long term physical and mental health conditions herself, including multiple sclerosis. She has particular expertise in good patient engagement practices and development of patient engagement strategies, diversity issues in healthcare and clinical research, communicating with patients, and patient involvement in scientific publications. Among the awards she has received, she has been recognized by the UK Prime Minister’s Office with a Points of Light Award for her work with patient communities. She is also a patron/ambassador for several healthcare organisations/charities, including MS Society UK and Lyfebulb, and is a Visiting Lecturer on Patient Engagement at King’s College London university.

Related news

Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Events September 7, 2022
MDIC Annual Patient Forum 2022
We are pleased to share that we will be joining as speakers MDIC Annual Patient Forum 2022 – a key platform for the discussion of how to transform patient engagement throughout the(...)
Clinical Trials MedTech Patient Engagement
Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Publications September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
Events August 10, 2022
DPHARM
We are pleased to announce that we will be sponsoring and attending DPHARM, a unique event focused on the latest innovations that modernize clinical trials.
Clinical Decentralized Clinical Trials DPHARM Patient Centric
Publications August 2, 2022
GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
The last two years have brought forward tremendous advances in the development of prophylactic and therapeutic approaches for the treatment of SARS-CoV-2 infections.
Clinical CMC Vaccines
Multimedia May 19, 2022
Fireside Chat Replay: Latest Developments in Oncology Supportive Care
In this fireside chat, we sit down with two medical experts in oncology and discuss some of the fascinating developments that are happening in the oncology supportive care field.
Clinical
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.